Parkworth Wealth Management’s Usana Health Sciences USNA Stock Holding History

Parkworth Wealth Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$305	Buy	+10	New	+$284	﹤0.01%	790

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Parkworth Wealth Management's USNA Position: Q2 2025 in Review

Parkworth Wealth Management opened a new position in Usana Health Sciences (USNA) in Q2 2025: 10 shares worth $305. The stake represents ﹤0.01% of the portfolio and ranks #790 among its holdings.

164 funds tracked by Wall St. Rank hold USNA as of Q2 2025.

Parkworth Wealth Management held 10 shares of Usana Health Sciences worth $305 as of Q2 2025.
Usana Health Sciences was a new Parkworth Wealth Management position in Q2 2025.
Usana Health Sciences made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #790 holding.
164 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.